Sunday, June 20, 2004

Health Canada warns of cholesterol drug risks
Health Canada has issued a warning about a potentially dangerous condition linked to Crestor, one of the "statin" drugs used to lower cholesterol.

The medication, when taken by patients with certain other health problems, can cause a condition in which muscle cells break down, leading in some cases to kidney failure and even death, says an advisory letter issued to physicians.

AstraZeneca of Mississauga, Ont., Crestor's manufacturer, said eight Canadians taking the drug have experienced the condition - called rhabdomyolysis - since February 2003. All had underlying conditions which increased their risk of developing the muscle-destroying side-effect.

No comments: